File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Valganciclovir thrice weekly for prophylaxis against cytomegalovirus reactivation during alemtuzumab therapy

TitleValganciclovir thrice weekly for prophylaxis against cytomegalovirus reactivation during alemtuzumab therapy
Authors
Hwang, YYCheung, WWWLeung, AYHTse, EAu, WYKwong, YL
Issue Date2009
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu
Citation
Leukemia, 2009, v. 23 n. 4, p. 800-801 How to Cite?
DOI: http://dx.doi.org/10.1038/leu.2008.282
Persistent Identifierhttp://hdl.handle.net/10722/59310
ISSN
0887-6924
2023 Impact Factor: 12.8
2023 SCImago Journal Rankings: 3.662
ISI Accession Number ID
WOS:000265220800025
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorHwang, YYen_HK
dc.contributor.authorCheung, WWWen_HK
dc.contributor.authorLeung, AYHen_HK
dc.contributor.authorTse, Een_HK
dc.contributor.authorAu, WYen_HK
dc.contributor.authorKwong, YLen_HK
dc.date.accessioned2010-05-31T03:47:29Z-
dc.date.available2010-05-31T03:47:29Z-
dc.date.issued2009en_HK
dc.identifier.citationLeukemia, 2009, v. 23 n. 4, p. 800-801en_HK
dc.identifier.issn0887-6924en_HK
dc.identifier.urihttp://hdl.handle.net/10722/59310-
dc.languageengen_HK
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leuen_HK
dc.relation.ispartofLeukemiaen_HK
dc.subject.meshAntibodies, Monoclonal - administration & dosageen_HK
dc.subject.meshAntibodies, Monoclonal, Humanizeden_HK
dc.subject.meshAntibodies, Neoplasm - administration & dosageen_HK
dc.subject.meshCytomegalovirus - drug effectsen_HK
dc.subject.meshDrug Evaluationen_HK
dc.subject.meshGanciclovir - administration & dosage - analogs & derivativesen_HK
dc.subject.meshHumansen_HK
dc.subject.meshPremedicationen_HK
dc.subject.meshVirus Activation - drug effectsen_HK
dc.titleValganciclovir thrice weekly for prophylaxis against cytomegalovirus reactivation during alemtuzumab therapyen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0887-6924&volume=23&spage=800–801&epage=&date=2008&atitle=Valganciclovir+thrice+weekly+for+prophylaxis+against+cytomegalovirus+reactivation+during+alemtuzumab+therapyen_HK
dc.identifier.emailLeung, AYH:ayhleung@hku.hken_HK
dc.identifier.emailTse, E:ewctse@hku.hken_HK
dc.identifier.emailKwong, YL:ylkwong@hku.hken_HK
dc.identifier.authorityLeung, AYH=rp00265en_HK
dc.identifier.authorityTse, E=rp00471en_HK
dc.identifier.authorityKwong, YL=rp00358en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1038/leu.2008.282en_HK
dc.identifier.pmid18843288-
dc.identifier.scopuseid_2-s2.0-64849107663en_HK
dc.identifier.hkuros156880en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-64849107663&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume23en_HK
dc.identifier.issue4en_HK
dc.identifier.spage800en_HK
dc.identifier.epage801en_HK
dc.identifier.isiWOS:000265220800025-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridHwang, YY=26532944100en_HK
dc.identifier.scopusauthoridCheung, WWW=8615134400en_HK
dc.identifier.scopusauthoridLeung, AYH=7403012668en_HK
dc.identifier.scopusauthoridTse, E=7005019454en_HK
dc.identifier.scopusauthoridAu, WY=7202383089en_HK
dc.identifier.scopusauthoridKwong, YL=7102818954en_HK
dc.identifier.citeulike3472446-
dc.identifier.issnl0887-6924-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats